Centessa Pharmaceuticals(CNTA) - 2023 Q2 - Quarterly Report

The Company's unaudited interim consolidated financial statements include the accounts of Centessa Pharmaceuticals plc, and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Emerging Growth Company and Smaller Reporting Company We are an "emerging growth company," as defined in the Jumpstart Our Business Startups Act ("JOBS Act") enacted in April 2012. For so long as we remain an emerging growth company, we are permitted and intend to rely on ce ...